| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Epoprostenol | FAERS: 28 | US FAERS | |
| 2 | carbidopa, levodopa drug combination | FAERS: 12 | US FAERS | |
| 3 | Baclofen | FAERS: 6 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 4 | treprostinil | FAERS: 4 | OFFSIDES US FAERS | |
| 5 | ambrisentan | FAERS: 3 | US FAERS | |
| 6 | apixaban | FAERS: 3 | US FAERS | |
| 7 | Fondaparinux | FAERS: 2 | OFFSIDES US FAERS | |
| 8 | Rivaroxaban | FAERS: 2 | US FAERS | |
| 9 | paricalcitol | FAERS: 2 | US FAERS | |
| 10 | reviparin | FAERS: 2 | US FAERS | |
| 11 | Dabigatran | FAERS: 1 | US FAERS | |
| 12 | Dasatinib | FAERS: 1 | US FAERS | |
| 13 | Dimethyl Fumarate | FAERS: 1 | US FAERS | |
| 14 | Ferric Oxide, Saccharated | FAERS: 1 | US FAERS | |
| 15 | Ketorolac Tromethamine | FAERS: 1 | US FAERS | |
| 16 | Milnacipran | FAERS: 1 | US FAERS | |
| 17 | Octreotide | FAERS: 1 | US FAERS | |
| 18 | Risperidone | FAERS: 1 | US FAERS | |
| 19 | Sirolimus | FAERS: 1 | US FAERS | |
| 20 | Trabectedin | FAERS: 1 | US FAERS | |
| 21 | gemcitabine | FAERS: 1 | US FAERS | |
| 22 | insulin glulisine | FAERS: 1 | US FAERS | |
| 23 | ioversol | FAERS: 1 | US FAERS | |
| 24 | macitentan | FAERS: 1 | US FAERS | |
| 25 | riociguat | FAERS: 1 | US FAERS | |
| 26 | Aprepitant | OFFSIDES | ||
| 27 | Bosentan | OFFSIDES | ||
| 28 | Chlorhexidine | OFFSIDES | ||
| 29 | Clofarabine | OFFSIDES | ||
| 30 | Diphenoxylate | OFFSIDES | ||
| 31 | Eptifibatide | OFFSIDES | ||
| 32 | Etoposide | OFFSIDES | ||
| 33 | Leucovorin | OFFSIDES | ||
| 34 | Mesna | OFFSIDES | ||
| 35 | Methyldopa | OFFSIDES | ||
| 36 | Tirofiban | OFFSIDES | ||
| 37 | calcium acetate | OFFSIDES | ||
| 38 | chlorhexidine gluconate | OFFSIDES | ||
| 39 | rofecoxib | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.